Galectin files for subscription rights offering – Seeking Alpha

Galectin files for subscription rights offering Seeking Alpha

Galectin Therapeutics (GALT) has filed a prospectus for a subscription rights offering of up to 14019137 common shares and warrants to purchase up to 3,5.

About The Author

Scroll to Top